Botanical species · safety record

Justicia pectoralis

The EFSA Compendium of Botanicals holds 13 constituent measurements for Justicia pectoralis. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Justicia pectoralis Jacq.

13Constituent measurements

0Safety records

6Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Benzaldehyde	Leaves	Essential oil	2.1 Percent	—	Resolve DOI
Coumarin	Leaves	Essential oil	7.4 Percent	—	Resolve DOI
Coumarin	Aerial part of plants	Solvent extraction	≤ 16.2 Gram/kilogram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Coumarin	Aerial part of plants	Solvent extraction	≥ 2.39 Gram/kilogram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Coumarins	Leaves	—	—	Unspecified	Resolve DOI
Justicidin b	Live plants	Solvent extraction	—	Chromatographic tests	Resolve DOI
Lignans	Leaves	—	—	Unspecified	Resolve DOI
Tannins	Leaves	—	—	Unspecified	Resolve DOI
Umbelliferone	Aerial part of plants	Solvent extraction	≤ 0.81 Gram/kilogram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Umbelliferone	Leaves	—	—	Unspecified	Resolve DOI
Umbelliferone	Aerial part of plants	Solvent extraction	≥ 0.78 Gram/kilogram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Coumarin	—	—	—	—	No resolvable identifier
Saponins	Aerial part of plants	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Rodrigues, E., Mendes, F.R., Negri, G. Plants indicated by Brazilian Indians for disturbances of the central nervous system: A bibliographical survey. Central nervous system agents in medicinal chemistry, 2006, vol. 6, no. 3, p. 211-244. DOI
Fonseca, Francisco N., Silva, Aline Holanda., Leal, Luzia K. A. M. Justicia pectoralis Jacq., Acanthaceae: preparation and characterisation of the plant drug including chromatographic analysis by HPLC-PDA . Revista brasileira de farmacognosia-brazilian journal of pharmacognosy, 2010, vol. 20, no. 6, p. 871-877. DOI
Pino, Jorge A. Volatile Constituents from Leaves of Justicia pectoralis Jacq. var. tipo. Journal of essential oil bearing plants, 2011, vol. 14, no. 2, p. 161-163. DOI
Rodr�guez Chanfrau, Jorge E., Roche, Ayme., Vega, Raiza., Rodr�guez, Carlos., Carballo, Caridad., Guerra, Isbet., Carrillo, Carmen. Estudios preliminares de extractos fluidos 30 % de Justicia pectoralis Jacq. var. stenophylla Leonard. . Revista cubana de plantas medicinales, 2008, vol. 13, no. 4, p. 0-0.
Leal, L. K. A. M., Silveira, E. R., Canuto, K. M., Matos, F. J. A., Viana, G. S. B., Singh, V. K., Arunachalam, C. Overview of chemical, toxicological and pharmacological studies with Amburana cearensis A.C. Smith and its active constituents. Recent progress in medicinal plants, 2006, p. 333-353.
JOSEPH, H., GLEYE, J., MOULIS, C., MENSAH, LJ., ROUSSAKIS, C., GRATAS, C. JUSTICIDIN-B, A CYTO-TOXIC PRINCIPLE FROM JUSTICIA-PECTORALIS. JOURNAL OF NATURAL PRODUCTS, 1988, vol. 51, no. 3, p. 599-600. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature